肺癌早期诊断研究进展  

Advances in Early Diagnosis of Lung Cancer

作　　者：刘一臻[1] 王明荣[1] 

机构地区：[1]中国医学科学院北京协和医学院肿瘤医院肿瘤研究所分子肿瘤学国家重点实验室,北京100021

出　　处：《中国肺癌杂志》2011年第5期429-434,共6页Chinese Journal of Lung Cancer

基　　金：卫生行业公益专项基金(No.200902002-4)资助~~

摘　　要：肺癌是绝大多数国家主要的癌症死亡原因,早期诊断和早期治疗尤为重要。以胸部X光片、螺旋CT、支气管内镜、痰液细胞学等检测手段用于肺癌的筛检和早诊已有较多报道,但鉴于以上检查手段的敏感性、特异性、适用度等方面的局限,近年来国内外学者对有关肺癌早期诊断的分子标志物做了大量有益的探索,本文拟就该领域的相关进展作一综述。Lung cancer is the most common cause of cancer death worldwide. Early diagnosis and early treatment are of great importance. Chest X-ray,spinal CT,bronchoscopy and sputum cytology have long been used as screening or diagnostic modalities for early detection of lung cancer. However,these methods have limitations in sensitivity,specificity or utility in some degree. In recent years,researchers all over the world have done lots of work on finding and identifying biomarkers for the early diagnosis of lung cancer. In this paper,recent deveploments in this field are reviewed.

关 键 词：肺肿瘤 早期诊断 分子标志物 

分 类 号：R734.2[医药卫生—肿瘤]